A Retrospective Study Comparing Signal-Enhancing Effect Gadobutrol and Gadoterate meglumine Intra-individually in Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate
Latest Information Update: 26 Feb 2020
At a glance
- Drugs Gadobutrol (Primary) ; Gadoterate-meglumine (Primary)
- Indications Benign prostatic hyperplasia; Prostate cancer
- Focus Diagnostic use
Most Recent Events
- 26 Feb 2020 New trial record